Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01717651 · ClinicalTrials.gov registry record
Muscle Atrophy in Patients With Severe Sepsis
A clinical trial, sponsored by Ohio State University.
- Terminated
- Registry status
- 25
- Enrollment target
NCT01717651: Clinical Trial study, sponsored by Ohio State University.
NCT01717651 is a clinical trial that was terminated before completion, run by Ohio State University. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01717651 was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- 25 participants
- Enrollment target
Study Summary
This study is being done to help determine whether patients with severe sepsis (overwhelming inflammation in the body as a result of an infection) lose muscle and become weak more rapidly than patients with other severe illnesses. Weakness and muscle loss that develops after a severe illness is a serious problem. Patients who develop weakness and have a decrease in muscle size often have to stay in the hospital longer and have a higher chance of dying. At the current time, it is not clear whether certain severe illnesses are more likely to cause weakness and muscle loss. This study will be done to measure the changes in muscle size and strength as a result of each patient's illness
Primary Outcome
Serial measures of quadriceps muscle by non-invasive ultrasound on Day of enrollment and Day 7 after enrollment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-02 |
Why NCT01717651 stopped before completion
NCT01717651 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01717651 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01717651 about?
NCT01717651 is a clinical study titled "Muscle Atrophy in Patients With Severe Sepsis". This study is being done to help determine whether patients with severe sepsis (overwhelming inflammation in the body as a result of an infection) lose muscle and become weak more rapidly than patients with other severe illnesses. Weakness and muscle loss that develops after a severe illness is a se...
What is the current status of trial NCT01717651?
This trial is currently terminated. The enrollment target is 25 participants. The study started on 2011-12. Estimated completion is 2013-02.
Who is sponsoring clinical trial NCT01717651?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia